Нестареющее тело. Научное исследование о том, как защитить свои тело и мозг и не допустить развития неврологических заболеваний

4. Taylor KSM, Counsell CE, Harris CE, Gordon JC. Screening for undiagnosed parkinsonism in people aged 65 years and over in the community. Parkinsonism & Related Disorders. 2006;12(2):79–85.

5. Nicoletti A, Sofia V, Bartoloni A, et al. Prevalence of Parkinson’s disease: a door-to-door survey in rural Bolivia. Parkinsonism & Related Disorders. 2003;10(1):19–21.

6. Kis B, Schrag A, Ben-Shlomo Y, et al. Novel three-stage ascertainment method: prevalence of PD and parkinsonism in South Tyrol, Italy. Neurology. 2002;58(12):1820–1825.

7. Muangpaisan W, Hori H, Brayne C. Systematic review of the prevalence and incidence of Parkinson’s disease in Asia. Journal of Epidemiology. 2009;19(6):281–293.

8. Schoenberg BS, Anderson DW, Haerer AF. Prevalence of Parkinson’s disease in the biracial population of Copiah County, Mississippi. Neurology. 1985;35(6):841–845.

9. Safarpour D, Thibault DP, DeSanto CL, et al. Nursing home and end-of-life care in Parkinson disease. Neurology. 2015;85(5):413–419.

10. Buchanan RJ, Wang S, Huang C, Simpson P, Manyam BV. Analyses of nursing home residents with Parkinson’s disease using the minimum data set. Parkinsonism & Related Disorders. 2002;8(5):369–380.

11. Weerkamp NJ, Zuidema SU, Tissingh G, et al. Motor profile and drug treatment of nursing home residents with Parkinson’s disease. Journal of the American Geriatrics Society. 2012;60(12):2277–2282.

12. Safarpour D, Thibault DP, DeSanto CL, et al. Nursing home and end-of-life care in Parkinson disease. Neurology. 2015;85(5):413–419.

13. Weerkamp NJ, Tissingh G, Poels PJE, et al. Diagnostic accuracy of Parkinson’s disease and atypical parkinsonism in nursing homes. Parkinsonism & Related Disorders. 2014;20(11):1157–1160.

14. Willis AW, Schootman M, Evanoff BA, Perlmutter JS, Racette BA. Neurologist care in Parkinson disease: a utilization, outcomes, and survival study. Neurology. 2011;77(9):851–857.

15. Там же.

16. Там же.

17. Papanicolas I, Woskie LR, Jha AK. Health care spending in the United States and other high-income countries. JAMA. 2018;319(10): 10241039; Dahodwala N, Xie M, Noll E, Siderowf A, Mandell DS. Treatment disparities in Parkinson’s disease. Annals of Neurology. 2009;66(2):142–145.

18. Willis AW, Schootman M, Evanoff BA, Perlmutter JS, Racette BA. Neurologist care in Parkinson disease: a utilization, outcomes, and survival study. Neurology. 2011;77(9):851–857.

19. Willis AW, Schootman M, Kung N, Wang X-Y, Perlmutter JS, Racette BA. Disparities in deep brain stimulation surgery among insured elders with Parkinson disease. Neurology. 2014;82(2):163–171.

20. Willis AW, Schootman M, Tran R, et al. Neurologist-associated reduction in PD-related hospitalizations and health care expenditures. Neurology. 2012;79(17):1774–1780.

21. Gage H, Hendricks A, Zhang S, Kazis L. The relative health related quality of life of veterans with Parkinson’s disease. Journal of Neurology, Neurosurgery, and Psychiatry. 2003;74(2):163–169.

22. Seidman C. Caring for wife with dementia leads husband to contemplate suicide. Sarasota Herald-Tribune. July 12, 2018; Opinion.

23. Caregiving in the U.S. 2015—executive summary. National Alliance for Caregiving. June 2015. www.caregiving.org/wp-content/ uploads/2015/05/2015_CaregivingintheUS_Executive-Summary-June-4 WEB.pdf. Accessed June 27, 2019.

24. Schrag A, Hovris A, Morley D, Quinn N, Jahanshahi M. Caregiverburden in Parkinson’s disease is closely associated with psychiatric symptoms, falls, and disability. Parkinsonism & Related Disorders. 2006;12(1):35–41.

25. Schulz R, Beach SR. Caregiving as a risk factor for mortality: the caregiver health effects study. JAMA. 1999;282(23):2215–2219.

26. Ahlskog JE. Beating a dead horse: dopamine and Parkinson disease. Neurology. 2007;69(17):1701–1711.